Clinical Trials · NCT00254397
Melanoma Vaccine With Peptides and Leuprolide
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 98
- Start date
- Nov 2005
- Locations
- 1 site, United States
- Primary endpoint
- Number of Participants With T-cell Response to Peptide Vaccine